Abstract Cardiovascular disease is one of the leading causes of death among reproductive-age women. In this study, we examine trends in the prevalence of dyslipidemia, hypertension, and related clinicians' advice among reproductive-age women. We conducted trend analysis of these factors among non-pregnant women aged 20-49 years (n = 5,768) using National Health and Nutrition Examination Survey (NHANES) data obtained between 1999 and 2008. Multiple linear regression and logistic regression analyses were used to examine linear trends over a 10-year period after adjusting for covariates. A downward trend was observed for the proportion of women with abnormal levels of low density lipoprotein (LDL; P = 0.038) and high density lipoprotein (HDL; P = 0.008) cholesterol from 1999 to 2008. In contrast, no significant changes were observed in the prevalence of abnormal total cholesterol (P = 0.948) and triglyceride levels (P = 0.300), or hypertension (P = 0.632). Based on the self-reported data, upward trends were observed in the rates of cholesterol checking (P = 0.002), high cholesterol (P = 0.012), receiving clinicians' advice to use lipid-lowering agents (P \ 0.001) and patients' compliance with their advice (P \ 0.001). Although rates of self-reported hypertension did not change over time (P = 0.120), receiving clinicians' advice to use antihypertensive medications (P = 0.003) and patients' compliance with these medications (P = 0.015) also increased significantly. Overall improvements in LDL and HDL cholesterol over this time period could be due to increases in related awareness, receiving advice to use medications, and patients' compliance with this advice. Use of antihypertensive medication has also increased among reproductive-age women in the US.
Introduction
Cardiovascular disease (CVD) risk factors are widely prevalent in reproductive-age women; 66 % are currently overweight or obese [1] , 11 % have dyslipidemia, and 8 % have hypertension [2] . As both dyslipidemia and hypertension have reproductive health consequences, awareness, identification and management of these conditions are important to prevent related morbidity and mortality in young women. For example, dyslipidemia is associated with polycystic ovary syndrome [3] , a leading cause of infertility [4] . It has also been reported that dyslipidemia during pregnancy may exert adverse effects on the mother including preeclampsia and gestational diabetes [5] [6] [7] , which are well recognized risk-factors for the development of type 2 diabetes and CVD in later life [8, 9] . Hypertension during pregnancy is also associated with preeclampsia, placental abruption, preterm delivery, low birth weight, and infant death [10] [11] [12] [13] . Moreover, hypertensive disorders in pregnancy increase the risk of death from CVD among reproductive-age women [14] .
Several US studies have used public data to report trends of major lipid fractions in the US, self-reported high cholesterol and use of lipid-lowering medications as well as the prevalence of hypertension and use of antihypertensive medications [15] [16] [17] [18] [19] [20] [21] . However, these studies have not examined the trends among women of reproductive-age using data generated during the last decade. Moreover, trends in clinicians' advice and patients' compliance with their advice to reduce hypercholesterolemia and hypertension have not been reported.
The objectives of this study were to examine recent trends among young women in the prevalence of dyslipidemia and hypertension as well as self-reported hypercholesterolemia and hypertension, clinicians' advice to patients with regard to lipid-lowering and antihypertensive medications, and patients' compliance with their recommendations.
Methods

Study Population
NHANES 1999-2008 is a continuous, cross-sectional survey conducted by the National Center for Health Statistics/ Center for Disease Control and Prevention (NCHS/CDC). The data are released in 2-year cycles. Each cycle included a nationally representative sample of the noninstitutionalized US civilian population selected through a complex, stratified, multistage probability sampling design. Detailed methods of this survey have been published [22] . Participants first received a detailed in-person home interview, followed by a visit to a mobile examination center for the administration of additional questionnaires, a physical examination, and laboratory tests.
This study used data on reproductive-age women (20- [22] . This study used de-identified publicly available data and thus was exempt from full review by the institutional review board at the University of Texas Medical Branch.
Data Collection
This study analyzed serum lipids and blood pressure (BP) data, self-reported high cholesterol, high BP, use of lipidlowering and antihypertensive medications as well as clinicians' advice and patients' compliance with this advice to reduce high cholesterol and BP. Demographic variables, body mass index (BMI), and waist circumference (WC) data were also included. BMI was stratified C25 kg/m 2 (combined overweight and obesity) and BMI C30 kg/m 2 (obesity). Age was calculated using years data. Race/ethnicity was determined by a self-report and categorized as non-Hispanic white, non-Hispanic black, Hispanic and other (American Indian, Native Alaskan, Asian or Pacific Islander, and other race not specified). Information about education level, marital status, smoking status and annual income were obtained by self-report [22] .
Low-density lipoprotein (LDL) cholesterol and triglyceride (TG) levels were based on morning samples taken after fasting for 8-24 h whereas total cholesterol (TC) and high density lipoprotein (HDL) cholesterol levels were based on samples taken regardless of fasting [15, 16, [23] [24] [25] . Methods for measuring, calculating, and analyzing all lipid fractions for NHANES 1999 to 2006 surveys have previously been reported [15] [16] [17] [18] 26] . From 2007 to 2008, the laboratory methods were same as previous years, but there were changes in the laboratory site (from the Johns Hopkins University to the University of Minnesota) and analyzing instrument (from Roche Hitachi 717 and 912 to Roche Modular P chemistry) for lipids testing [23] [24] [25] . The measurements of TC, TG and HDL cholesterol were standardized for each NHANES survey according to the CDC Lipid Standardization Program [15, 16, 27] , wherein the HDL cholesterol values were found to be within the 5 % maximum allowable bias [25] . LDL cholesterol was calculated according to the Friedewald equation (serum TC-HDL cholesterol-serum TG/5) for serum TG levels B400 mg/dl [23, 28] . Abnormal TC (C200 mg/dl), LDL cholesterol (C130 mg/dl), HDL cholesterol (\40 mg/dl), and TG (C150 mg/dl) were categorized based on a criteria from the NCEP ATP III [29] .
Self-reported data on cholesterol checking, high cholesterol, clinicians' advice with regard to life style changes (eating less high fat/cholesterol food, controlling/losing weight, and increasing physical activity/exercise) and medication use for high cholesterol, and patients' compliance with their clinicians' advice were obtained by selfreport. Self-reported lipid medication use was confirmed by assessing the prescription dataset for the NHANES 1999-2008.
Blood pressure (BP) was measured 3-4 times using a sphygmomanometer [20] . We calculated mean SBP and DBP (mean ± SE) as the average of these measures after excluding the first measurement [30, 31] . We also obtained self-reported data on hypertension, clinicians' advice to use antihypertensive medication, and patients' compliance with these medications. We assessed the prescription dataset for the NHANES 1999-2008 to confirm any antihypertensive medication use (a report of using one or more of these medications). Actual hypertension, defined as mean SBP C140 mm Hg or a mean DBP C90 mm Hg or both, or current treatment with prescription medications to control BP (\140 mm Hg and \90 mm Hg) was also examined [20, 21, 31, 32] .
Statistical Analysis
All analyses were conducted using STATA 10 svy commands (STATA Corporation, College Station, TX) according to NHANES analytical guidelines by taking into account survey weighting for the complex survey design, which consisted of multistage, stratified, clustered samples [33] . Probability sampling weights were used in conjunction with strata and primary sampling units (psu) to weight the analysis. Simple descriptive statistics were used to describe the study population for each of the five 2-year study cycles. Variance of proportions was estimated with Taylor series linearization. We used multivariate analyses using multiple linear regression and logistic regression analyses to examine the trend of different parameters over the five 2-year survey cycles from 1999 to 2008, after adjusting for age, race/ethnicity, and survey cycles. Age and survey cycles were treated as continuous variables.
Results
Overall, the proportion of 20-49 year old Hispanic women increased steadily over the 10-year period (P \ 0.001) while other races (American Indian, Native Alaskan, Asian or Pacific Islander, and other race not specified) decreased significantly (P \ 0.001) Education, marital status, household income, and current smoking status of these women did not change significantly over the intervals (Table 1) . No significant changes were observed between 1999 and 2008 in the proportion of reproductive-age women with abnormal TC (P = 0.948) or TG (P = 0.300) between 1999 and 2008. The proportion of women with abnormal LDL (C130 mg/dl) and HDL cholesterol (\40 mg/dl) did decrease significantly from 32 % to 25 % (P = 0.038) and 16 % to 13 % (P = 0.008), respectively (Fig. 1) . Trend analysis based on mean levels of LDL and HDL also showed positive directions (Fig. 2) . Mean HDL cholesterol rose from 52.9 mg/dl to 56.4 mg/dl (P \ 0.001), while mean LDL cholesterol declined from 117.2 mg/dl to 110.5 mg/dl (P \ 0.001) over the 10-year period. Significant changes were not observed for mean TC (P = 0.275) and TG (P = 0.270) levels.
Based on self-reported data, we observed that the proportion of women who had their cholesterol level checked and were labeled to have hypercholesterolemia increased significantly over the 10-year period (P = 0.002 and P = 0.012, respectively) ( Table 2 ). In addition, the proportion of women who received advice from a clinician to reduce their cholesterol level and were compliant with this advice also increased. The proportion of women who were labeled as hypertensive on C2 occasions did increase from 10 % in 1999-2000 to 13 % in 2007-2008, but did not achieve statistical significance (P = 0.120) ( Table 3 ). The proportion who received advice from their clinician to use medication for hypertension increased significantly from 8 % to 12 % (P = 0.003) and their compliance with this recommendation increased from 6 % to 9 % (P = 0.015) during this same period. However, the proportion of women with actual hypertension did not change significantly (P = 0.632) over the 10-year period.
Discussion
We found a significant downward trend in mean LDL cholesterol and the percentage of women with abnormal LDL cholesterol (C130 mg/dl) between 1999 and 2008. [15] [16] [17] . However, we did not find any significant changes in mean TC or the prevalence of abnormal TC (C200 mg/dl) in contrast to Cohen et [16] . Improvements in LDL and HDL cholesterol levels during this interval could be due to the fact that an increased proportion of women reported checking their blood cholesterol, having been diagnosed with high cholesterol, receiving advice from their clinicians to modify their lifestyle or using medication to reduce their cholesterol. We observed that mean TG and the prevalence of abnormal TG (C150 mg/dl) did not show any upward trend among reproductive-age women in the last decade. Cohen et al. [16] , on the other hand, found an upward trend in mean TG and the prevalence of abnormal TG based on all adults when comparing the 1988-1994 to the 1999-2006 NHANES waves. It has been reported that dietary and lifestyle modifications, including body weight control, regular physical activity, less fat intake, low carbohydrate diet, and smoking cessation, are first-line therapy for all lipid disorders, especially hypertriglyceridemia [29, 34] . Significant increases in recommendations for lifestyle modification and patients' compliance with these among reproductive-age women since 1999-2000 may have played an important role in this regard. However, our finding that abdominal obesity (WC [88 cm) and combined overweight and obesity (C25 kg/m 2 ) significantly increased among these women over the 10 years is concerning. As elevated triglyceride levels are strongly correlated with increased WC and BMI [35] [36] [37] , measures need to be taken to control obesity to avoid adverse consequence on lipids and other risks for CVD.
Our finding that the prevalence of hypertension did not change significantly among reproductive-age women between 1999 and 2008 is in agreement with Egan et al.'s study [21] based on all adult women for the same time frame. Although the proportion of women with selfreported hypertension on C2 occasions did not increase significantly over time, the rates gradually reached almost the same level of actual hypertension (12.9 % vs. 12.4 %) during the 2007-2008 period, which indicates gradual increase in awareness regarding hypertension. The selfreported rates of receiving clinicians' advice to use antihypertensive medications and patients' compliance with these medications were consistent with the findings reported by several other studies based on data from different NHANES cycles [21, 31, 38] .
Identifying dyslipidemia and hypertension is very important in reproductive-age women to prevent pregnancy related complications as well as CVD in later life. Our study observed a gradual improvement in lipid profiles, an unchanged hypertension prevalence, and higher frequency of clinicians' advice and patient compliance with this advice over the 10-year period. Early interventions targeted at this group may help improve the scenario even further. Future trend analysis with regard to dyslipidemia and hypertension related complications, such as polycystic ovary syndrome, infertility, preeclampsia, placenta abruption, preterm delivery, low birth weight, and infant death over time may shed more light on the impact of these improvements among young women.
The strengths of our study include use of a database with a nationally representative large sample, standardized protocols, in-person household interviews, and standard laboratory procedures. Despite these strengths, the study has several limitations. First, cross-sectional survey data prevents our ability to establish causal relationships or pathways to the trends we observed. Second, although the collection of examination and laboratory data were standardized, self-reported data from interviews and questionnaires are subject to bias. Third, our study population was limited to 20-49 year old women. Thus, our findings may not be applicable to older women who are at higher risk of hypertension, lipid disorders and CVD. Fourth, statistical significance trends may not be always meaningful as one extreme value may have influenced the significance level of the trend test. So caution should be taken when interpreting statistical significance. Finally, BP measurements were performed only at a single time point while a clinical diagnosis of hypertension is based on the average of C2 properly measured BP readings on 2 separate occasions. It is therefore possible that some subjects were misclassified with regard to their hypertension status.
In conclusion, the results from this study suggest that reproductive-age women have been experiencing a gradual improvement in both LDL and HDL cholesterol levels, although other lipid fractions and prevalence of hypertension remain almost unchanged. Overall improvement with regard to LDL and HDL cholesterol among reproductiveage women may be due to an increase in awareness, or clinician recommendations to modify their lifestyle and use medications as well as improvement in patient compliance with this advice.
